Risk prediction for clonal cytopenia: multicenter real-world evidenceZhuoer Xie, Aref Al‐Kali, Rami S. Komrokji et al.|Blood|2024Cited by 51
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current eraAnand Patel, Olatoyosi Odenike, James Yoon et al.|Blood Advances|2024Cited by 32
Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World AnalysisMonika A. Izano, Shirish M. Gadgeel, Connor Sweetnam et al.|Clinical Lung Cancer|2023Cited by 10
Outcomes of Patients with Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Current Era of Myeloid TherapiesAnand Patel, Olatoyosi Odenike, James Yoon et al.|Blood|2022Cited by 6
The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal CytopeniasZhuoer Xie, Aref Al‐Kali, Rami S. Komrokji et al.|Blood|2022Cited by 6